These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15379699)

  • 1. Combining DNA damaging agents and checkpoint 1 inhibitors.
    Prudhomme M
    Curr Med Chem Anticancer Agents; 2004 Sep; 4(5):435-8. PubMed ID: 15379699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
    Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
    J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel checkpoint 1 inhibitors.
    Prudhomme M
    Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):55-68. PubMed ID: 18221026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage checkpoints: implications for cancer therapy.
    O'Connor PM; Fan S
    Prog Cell Cycle Res; 1996; 2():165-73. PubMed ID: 9552393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase III acts upstream of Rad53p in the S-phase DNA damage checkpoint.
    Chakraverty RK; Kearsey JM; Oakley TJ; Grenon M; de La Torre Ruiz MA; Lowndes NF; Hickson ID
    Mol Cell Biol; 2001 Nov; 21(21):7150-62. PubMed ID: 11585898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents.
    Céraline J; Deplanque G; Duclos B; Limacher JM; Hajri A; Noel F; Orvain C; Frébourg T; Klein-Soyer C; Bergerat JP
    Int J Cancer; 1998 Jan; 75(3):432-8. PubMed ID: 9455805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.
    Anderson HJ; Andersen RJ; Roberge M
    Prog Cell Cycle Res; 2003; 5():423-30. PubMed ID: 14593736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G2 and spindle assembly checkpoint adaptation, and tetraploidy arrest: implications for intrinsic and chemically induced genomic instability.
    Andreassen PR; Lohez OD; Margolis RL
    Mutat Res; 2003 Nov; 532(1-2):245-53. PubMed ID: 14643440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells.
    Koniaras K; Cuddihy AR; Christopoulos H; Hogg A; O'Connell MJ
    Oncogene; 2001 Nov; 20(51):7453-63. PubMed ID: 11709716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle checkpoint function in bladder cancer.
    Doherty SC; McKeown SR; McKelvey-Martin V; Downes CS; Atala A; Yoo JJ; Simpson DA; Kaufmann WK
    J Natl Cancer Inst; 2003 Dec; 95(24):1859-68. PubMed ID: 14679155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair.
    Weinert TA; Kiser GL; Hartwell LH
    Genes Dev; 1994 Mar; 8(6):652-65. PubMed ID: 7926756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage and p53-mediated cell cycle arrest: a reevaluation.
    Pellegata NS; Antoniono RJ; Redpath JL; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15209-14. PubMed ID: 8986789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells.
    Andreassen PR; Lacroix FB; Lohez OD; Margolis RL
    Cancer Res; 2001 Oct; 61(20):7660-8. PubMed ID: 11606409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian G1 and G2 phase checkpoints.
    O'Connor PM
    Cancer Surv; 1997; 29():151-82. PubMed ID: 9338101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
    Ashwell S; Zabludoff S
    Clin Cancer Res; 2008 Jul; 14(13):4032-7. PubMed ID: 18593978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe.
    Lindsay HD; Griffiths DJ; Edwards RJ; Christensen PU; Murray JM; Osman F; Walworth N; Carr AM
    Genes Dev; 1998 Feb; 12(3):382-95. PubMed ID: 9450932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive complex systems approach to the study and analysis of mammalian cell cycle control system in the presence of DNA damage stress.
    Abroudi A; Samarasinghe S; Kulasiri D
    J Theor Biol; 2017 Sep; 429():204-228. PubMed ID: 28647496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy.
    Vogel C; Kienitz A; Hofmann I; Müller R; Bastians H
    Oncogene; 2004 Sep; 23(41):6845-53. PubMed ID: 15286707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.
    Liu X; Guo Y; Li Y; Jiang Y; Chubb S; Azuma A; Huang P; Matsuda A; Hittelman W; Plunkett W
    Cancer Res; 2005 Aug; 65(15):6874-81. PubMed ID: 16061671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.